Combining rTMS With Intensive Language-Action Therapy in Chronic Aphasia: A Randomized Controlled Trial

被引:39
作者
Heikkinen, Paula H. [1 ]
Pulvermueller, Friedemann [2 ]
Makela, Jyrki P. [3 ,4 ]
Ilmoniemi, Risto J. [5 ]
Lioumis, Pantelis [6 ,7 ]
Kujala, Teija [8 ]
Manninen, Riitta-Leena [3 ,4 ]
Ahvenainen, Antti [3 ,4 ]
Klippi, Anu [1 ]
机构
[1] Univ Helsinki, Fac Med, Dept Psychol & Logoped, Helsinki, Finland
[2] Free Univ Berlin, Dept Philosophy & Humanities, Brain Language Lab, WE4, Berlin, Germany
[3] Univ Helsinki, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland
[4] Helsinki Univ Hosp, Helsinki, Finland
[5] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland
[6] Univ Toronto, Ctr Addict & Mental Hlth, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada
[7] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[8] Univ Helsinki, Fac Med, Dept Psychol & Logoped, Cognit Brain Res Unit, Helsinki, Finland
关键词
chronic aphasia; language rehabilitation; efficacy; ILAT; rTMS; randomized controlled trial (RCT); TRANSCRANIAL MAGNETIC STIMULATION; CONSTRAINT-INDUCED APHASIA; LOW-FREQUENCY RTMS; NONFLUENT APHASIA; CORTICAL EXCITABILITY; POSTSTROKE APHASIA; BRAIN-STIMULATION; CHRONIC STROKE; RECOVERY; NEUROSCIENCE;
D O I
10.3389/fnins.2018.01036
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuromodulation technologies, such as transcranial magnetic stimulation (TMS), are promising tools for neurorehabilitation, aphasia therapy included, but not yet in common clinical use. Combined with behavioral techniques, in particular treatment-efficient Intensive Language-Action Therapy (ILAT, previously CIAT or CILT), TMS could substantially amplify the beneficial effect of such behavioral therapy alone (Thiel et al., 2013; Martin et al., 2014; Mendoza et al., 2016; Kapoor, 2017). In this randomized study of 17 subjects with post-stroke aphasia in the chronic stage, we studied the combined effect of ILAT and 1-Hz placebo-controlled navigated repetitive TMS (rTMS) to the right-hemispheric inferior frontal cortex-that is, to the anterior part of the non-dominant hemisphere's homolog Broca's area (pars triangularis). Patients were randomized to groups A and B. Patients in group A received a 2-week period of rTMS during naming training where they named pictures displayed on the screen once every 10 s, followed by 2 weeks of rTMS and naming combined with ILAT. Patients in group B received the same behavioral therapy but TMS was replaced by sham stimulation. The primary outcome measures for changes in language performance were the Western Aphasia Battery's aphasia quotient AQ; the secondary outcome measures were the Boston naming test (BNT) and the Action naming test (Action BNT, ANT). All subjects completed the study. At baseline, no statistically significant group differences were discovered for age, post-stroke time or diagnosis. ILAT was associated with significant improvement across groups, as documented by both primary and secondary outcome measures. No significant effect of rTMS could be documented. Our results agree with previous results proving ILAT's ability to improve language in patients with chronic aphasia. In contrast with earlier claims, however, a beneficial effect of rTMS in chronic post-stroke aphasia rehabilitation was not detected in this study.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Neuroplasticity and Functional Recovery after Intensive Language Therapy in Chronic Post Stroke Aphasia: Which Factors Are Relevant?
    Mohr, Bettina
    FRONTIERS IN HUMAN NEUROSCIENCE, 2017, 11
  • [42] Protocol for Escitalopram and Language Intervention for Subacute Aphasia (ELISA): A randomized, double blind, placebo-controlled trial
    Stockbridge, Melissa D.
    Fridriksson, Julius
    Sen, Souvik
    Bonilha, Leonardo
    Hillis, Argye E.
    PLOS ONE, 2021, 16 (12):
  • [43] Effects and safety of combined rTMS and action observation for recovery of function in the upper extremities in stroke patients: A randomized controlled trial
    Noh, Jun Soo
    Lim, Ji Hoon
    Choi, Tae Woong
    Jang, Seung Gul
    Pyun, Sung-Bom
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 2019, 37 (03) : 219 - 230
  • [44] FCET2EC (From controlled experimental trial to=2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial
    Baumgaertner, Annette
    Grewe, Tanja
    Ziegler, Wolfram
    Floel, Agnes
    Springer, Luise
    Martus, Peter
    Breitenstein, Caterina
    TRIALS, 2013, 14
  • [45] Constrained Versus Unconstrained Intensive Language Therapy in Two Individuals With Chronic, Moderate-to-Severe Aphasia and Apraxia of Speech: Behavioral and fMRI Outcomes
    Kurland, Jacquie
    Pulvermueller, Friedemann
    Silva, Nicole
    Burke, Katherine
    Andrianopoulos, Mary
    AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY, 2012, 21 (02) : S65 - S87
  • [46] Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial
    Cole, Eleanor J.
    Phillips, Angela L.
    Bentzley, Brandon S.
    Stimpson, Katy H.
    Nejad, Romina
    Barmak, Fahim
    Veerapal, Clive
    Khan, Naushaba
    Cherian, Kirsten
    Felber, Emily
    Brown, Randi
    Choi, Elizabeth
    King, Sinead
    Pankow, Heather
    Bishop, James H.
    Azeez, Azeezat
    Coetzee, John
    Rapier, Rachel
    Odenwald, Nicole
    Carreon, David
    Hawkins, Jessica
    Chang, Maureen
    Keller, Jennifer
    Raj, Kristin
    DeBattista, Charles
    Jo, Booil
    Espil, Flint M.
    Schatzberg, Alan F.
    Sudheimer, Keith D.
    Williams, Nolan R.
    AMERICAN JOURNAL OF PSYCHIATRY, 2022, 179 (02) : 132 - 141
  • [47] Intensive Communicative Therapy Reduces Symptoms of Depression in Chronic Nonfluent Aphasia
    Mohr, Bettina
    Stahl, Benjamin
    Berthier, Marcelo L.
    Pulvermueller, Friedemann
    NEUROREHABILITATION AND NEURAL REPAIR, 2017, 31 (12) : 1053 - 1062
  • [48] Fluid Restriction Therapy for Chronic SIAD; Results of a Prospective Randomized Controlled Trial
    Garrahy, Aoife
    Galloway, Iona
    Hannon, Anne Marie
    Dineen, Rosemary
    O'Kelly, Patrick
    Tormey, William P.
    O'Reilly, Michael W.
    Williams, David J.
    Sherlock, Mark
    Thompson, Chris J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (12)
  • [49] Cell Therapy for Chronic TBI Interim Analysis of the Randomized Controlled STEMTRA Trial
    Kawabori, Masahito
    Weintraub, Alan H.
    Imai, Hideaki
    Zinkevych, Iaroslav
    McAllister, Peter
    Steinberg, Gary K.
    Frishberg, Benjamin M.
    Yasuhara, Takao
    Chen, Jefferson W.
    Cramer, Steven C.
    Achrol, Achal S.
    Schwartz, Neil E.
    Suenaga, Jun
    Lu, Daniel C.
    Semeniv, Ihor
    Nakamura, Hajime
    Kondziolka, Douglas
    Chida, Dai
    Kaneko, Takehiko
    Karasawa, Yasuaki
    Paadre, Susan
    Nejadnik, Bijan
    Bates, Damien
    Stonehouse, Anthony H.
    Richardson, R. Mark
    Okonkwo, David O.
    NEUROLOGY, 2021, 96 (08) : E1202 - E1214
  • [50] Extracorporeal Shockwave Therapy for Chronic Knee Pain: A Multicenter, Randomized Controlled Trial
    Wang, Tian-Shu
    Guo, Peng
    Li, Gang
    Wang, Jian-Wei
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2020, 26 (02) : 34 - 37